Recruiting × Leukemia, Myeloid, Accelerated Phase × Clear all Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Phase 1/2 Recruiting
70 enrolled
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Phase 1 Recruiting
46 enrolled
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Phase 2 Recruiting
90 enrolled
Personalized NK Cell Therapy in CBT
Phase 2 Recruiting
100 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
BMT-13
Phase 2 Recruiting
38 enrolled
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Phase NA Recruiting
40 enrolled
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Phase 2 Recruiting
40 enrolled
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
Phase 1 Recruiting
108 enrolled